BSX
Boston Scientific Corporation β’ Healthcare (#8 of 11)
$45.29
+0.34 (+0.76%)
View:
Close:$45.29
Vol:HIGH(85%ile)
Ratio:1.61x
|RSI:27(Oversold)
MACD:β
β₯75%25-75%<25%
Vol.%
Sector Rotation
2026-06-18(10/10)
20d Strength (bar)
Strong (Β±4%)
Normal (-2~+3%)
5d Strength (normal: -1~+1%)
Relative Strength Trajectory
5d Strength
10d Strength
20d Strength
NASDAQ
10d early: 3~5%|20d confirm: 4~8.5%|>8.5% exhaustion
Analyst Actions
NEUTRALβ²0 UpβΌ2 Down8 Hold
Jun 16BTIG
βBuy
Jun 4Truist Securities
βBuy
Jun 3BTIG
βBuy
Jun 1Canaccord Genuity
βBuy
May 29Wolfe Research
βΌOutperform β Peer Perform
May 28Citigroup
βBuy
May 28Leerink Partners
βOutperform
May 28Barclays
βOverweight
May 28Wells Fargo
βΌOverweight β Equal-Weight
May 19Baird
βOutperform
Price Targets
β²0 RaisesβΌ8 Lowers
Jun 16BTIG
$65β$65New
Jun 4Truist Securities
$85β$64-24.7%
Jun 3BTIG
$80β$65-18.8%
Jun 1Canaccord Genuity
$71β$70-1.4%
May 28Citigroup
$87β$70-19.5%
May 28Leerink Partners
$87β$74-14.9%
May 28Barclays
$96β$89-7.3%
May 28Wells Fargo
$75β$55-26.7%
May 19Baird
$78β$75-3.8%
Trade Setup
ATR-basedEntry$45.29
Target$48.69 (+7.5%)
Stop$42.74
R/R1.33
Risk-5.6%
ATR$1.70
Simple setup: 1.5x ATR stop, 2x ATR target
Risk Metrics
Sharpe (20d)
-5.53Losing
Volatility (20d)
48.6%High
Beta (60d)
0.46Defensive
Alpha (20d)
-21.0%Weak
News Analysis
EN
δΈ
ν
ζ₯
No analysis record found.